Justice Dept. Asks Supreme Court to Hear Abortion Pill Casenews2023-09-08T23:06:10+00:00September 8th, 2023|The New York Times|
F.D.A. Approves First U.S. Over-the-Counter Birth Control Pillnews2023-07-13T14:32:37+00:00July 13th, 2023|The New York Times|
FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|
Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEPnews2023-05-09T17:34:57+00:00May 9th, 2023|The New York Times|
Supreme Court Ensures, for Now, Broad Access to Abortion Pillnews2023-04-22T14:39:23+00:00April 22nd, 2023|The New York Times|
This Could Be One of the Most Brazen Attacks on Americans’ Health Yetnews2023-04-20T11:32:43+00:00April 20th, 2023|The New York Times|
Supreme Court Could Restrict Abortion Pill Todaynews2023-04-19T13:04:44+00:00April 19th, 2023|The New York Times|
Appeals Court Says Abortion Pill Can Remain Available but Imposes Temporary Restrictionsnews2023-04-13T14:42:18+00:00April 13th, 2023|The New York Times|
What Happens Next in the Mifepristone Abortion Drug Casenews2023-04-12T16:55:09+00:00April 12th, 2023|The New York Times|